MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 11, 2007; DOI: 10.1124/mol.107.042598


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.042598v1
73/3/718    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raccor, B. S
Right arrow Articles by Day, B. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raccor, B. S
Right arrow Articles by Day, B. W


Received for publication October 11, 2007.
Revised December 7, 2007.
Accepted for publication December 10, 2007.

Cell-Based and Biochemical Structure-Activity Analyses of Analogues of the Microtubule Stabilizer Dictyostatin

Brianne S Raccor 1, Andreas Vogt 1, Rachel P Sikorski 1, Charitha Madiraju 1, Raghavan Balachandran 1, Kia Montgomery 1, Youseung Shin 1, Yoshikazu Fukui 1, Won-Hyuk Jung 1, Dennis P Curran 1, Billy W Day 1*

1 University of Pittsburgh

* Address correspondence to: E-mail: bday{at}pitt.edu

Abstract

Compounds that bind to microtubules (MTs) and alter their dynamics are highly sought due to the clinical success of paclitaxel and docetaxel. The naturally occurring compound (-)-dictyostatin binds to MTs, causes cell cycle arrest in G2/M at nanomolar concentrations, and retains antiproliferative activity in paclitaxel-resistant cell lines, making dictyostatin an attractive candidate for development as an antineoplastic agent. Here we examined a series of dictyostatin analogues to probe biological and biochemical structure-activity relationships. We used a high-content multiparameter fluorescence based cellular assay for MT morphology, chromatin condensation, mitotic arrest and cellular toxicity to identify regions of dictyostatin that were essential for biological activity. Four analogues, namely 6-epi-dictyostatin, 7-epi-dictyostatin, 16-normethyldictyostatin and 15Z,16-normethyldictyostatin, retained low nanomolar activity in the cell-based assay and were chosen for analyses with isolated tubulin. All four compounds were potent inducers of MT assembly. Equilibrium binding constant (Ki) determinations using [14C]epothilone B, which has a three-fold higher affinity for the taxoid binding site than paclitaxel, indicated that 6-epi-dictyostatin and 7-epi-dictyostatin displaced [14C]epothilone B with Ki values of 480 nM and 930 nM, respectively. 16-Normethyldictyostatin and 15Z,16-normethyldictyostatin had reduced affinity (Ki values of 4.55 and 4.47 µM, respectively), consistent with previous reports showing that C16-normethyldictyostatin loses potency in paclitaxel-resistant cell lines that have a Phe270 to Val mutation in the taxoid binding site of {beta}-tubulin. Finally, we developed a set of QSAR equations correlating structures with antiproliferative activity. The equations accurately predicted biological activity and will help in the design of future analogues.


Key words: Structure-activity relationships and modeling, Fluorescence techniques, Cytoskeletal targets





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics